Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 12, 2011, Pages 1599-1605

  Ortega, M ^a   Marco, F ^a   Soriano, A ^a   Almela, M ^a   Martinez J A ^a   Lopez J ^a   Pitart, C ^a   Mensa, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BILIARY TRACT INFECTION; BLOOD CULTURE; BLOODSTREAM INFECTION; CATHETER INFECTION; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENZYME SYNTHESIS; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; INFECTION RISK; KLEBSIELLA; KLEBSIELLA INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; THERAPEUTIC ERROR; URINARY TRACT INFECTION;

EID: 85027957207     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1266-2     Document Type: Article

References (27)

1. K Skogberg O Lyytikainen P Ruutu J Ollgren JP Nuorti 2008 Increase in bloodstream infections in Finland, 1995-2002 Epidemiol Infect 136 108 114 17335630 10.1017/S0950268807008138 1:STN:280:DC%2BD2sjkvF2qtg%3D%3D
2. DZ Uslan SJ Crane JM Steckelberg, et al. 2007 Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota Arch Intern Med 167 834 839 17452548 10.1001/archinte.167.8.834 (Pubitemid 46658343)
3. AM Yinnon A Butnaru D Raveh Z Jerassy B Rudensky 1996 Klebsiella spp bacteraemia: community versus nosocomial infection QJM 89 933 941 9015487 1:STN:280:DyaK2s7mslyksg%3D%3D (Pubitemid 27016323)
4. R Podschun U Ullmann 1998 Klebsiella spp as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors Clin Microbiol Rev 11 589 603 9767057 1:STN:280:DyaK1cvktVemtQ%3D%3D (Pubitemid 28497563)
5. DR Chung SS Lee HR Lee, et al. 2007 Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea J Infect 54 578 583 17175028 10.1016/j.jinf.2006.11.008 1:STN:280:DC%2BD2s3pvFWhsw%3D%3D (Pubitemid 46731226)
6. CT Fang SY Lai WC Yi PR Hsueh KL Liu SC Chang 2007 Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess Clin Infect Dis 45 284 293 17599305 10.1086/519262 1:CAS:528:DC%2BD2sXptFSgs7k%3D (Pubitemid 47101023)
7. CP Fung FY Chang SC Lee, et al. 2002 A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50 420 424 11839725 10.1136/gut.50.3.420 (Pubitemid 34161062)
8. JH Wang YC Liu SS Lee, et al. 1998 Primary liver abscess due to Klebsiella pneumoniae in Taiwan Clin Infect Dis 26 1434 1438 9636876 10.1086/516369 1:STN:280:DyaK1czgtVGjtw%3D%3D (Pubitemid 28270178)
9. DL Paterson KM Hujer AM Hujer, et al. 2003 Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTXM- type -lactamases Antimicrob Agents Chemother 47 3554 3560 14576117 10.1128/AAC.47.11.3554-3560.2003 1:CAS:528:DC%2BD3sXovVaitLs%3D (Pubitemid 37345719)
10. M Ortega F Marco A Soriano, et al. 2009 Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome J Antimicrob Chemother 63 568 574 19126669 10.1093/jac/dkn514 1:CAS:528:DC%2BD1MXitVSitrw%3D
11. M Angel-Díaz J Ramón-Hernández L Martínez-Martínez J Rodríguez-Baños A Pascual Hospital Infection Study Group 2009 Extended-spectrum β-lactamase-producing E. coli and K. pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006) Enferm Infecc Microbiol Clin 27 503 510 19329230 10.1016/j.eimc.2008.09.006
12. RW Tsay LK Siu CP Fung FY Chang 2002 Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection Arch Intern Med 162 1021 1027 11996612 10.1001/archinte.162.9.1021 (Pubitemid 34492531)
13. Murray PR, Baron EJ, Jorgensen JH (eds) (2007) Manual of clinical microbiology, 9th edn. ASM Press, Washington, DC
14. Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement M100-S16. CLSI, Wayne, PA, USA
15. D Annane E Bellisant JM Cavaillon 2005 Septic shock Lancet 365 63 78 15639681 10.1016/S0140-6736(04)17667-8 1:CAS:528:DC%2BD2MXhvF2gsA%3D%3D (Pubitemid 40082148)
16. JS Garner WR Jarvis TG Emori TC Horan JM Hughes 1988 CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 128 140 2841893 10.1016/0196-6553(88)90053-3 1:STN:280:DyaL1czgvVSnug%3D%3D
17. F Blot G Nitenberg C Brun-Buisson 2000 New tools in diagnosing catheter-related infections Support Care Cancer 8 287 292 10923768 10.1007/s005200000150 1:STN:280:DC%2BD3M%2FlvVeqsQ%3D%3D (Pubitemid 30430051)
18. I Raad HA Hanna B Alakech I Chatzinikolaou MM Johnson J Tarrand 2004 Differential time to positivity: an useful method for diagnosing catheter-related infections Ann Intern Med 140 18 25 14706968
19. WR McCabe GG Jackson 1962 Gram-negative bacteremia. II. Clinical, laboratory and therapeutic observations Arch Intern Med 110 847 855
20. BL Meatherall D Gregson T Ross JD Pitout KB Laupland 2009 Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia Am J Med 122 866 873 19699383 10.1016/j.amjmed.2009.03.034
21. DL Paterson WC Ko A Von Gottberg, et al. 2004 Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases Clin Infect Dis 39 31 37 15206050 10.1086/420816 1:CAS:528:DC%2BD2cXmtlSgtr4%3D (Pubitemid 38879546)
22. H Goossens MYSTIC Study Group 2001 MYSTIC program: summary of European data from 1997 to 2000 Diagn Microbiol Infect Dis 41 183 189 11777657 10.1016/S0732-8893(01)00320-0 1:STN:280:DC%2BD38%2FltFOkug%3D%3D (Pubitemid 34056540)
23. B Du Y Long H Liu, et al. 2002 Extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome Intensive Care Med 28 1718 1723 12447513 10.1007/s00134-002-1521-1 (Pubitemid 35435472)
24. BN Kim JH Woo MN Kim J Ryu YS Kim 2002 Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia J Hosp Infect 52 99 106 12392901 10.1053/jhin.2002.1288 (Pubitemid 38001939)
25. DA Schiappa MK Hayden MG Matushek, et al. 1996 Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation J Infect Dis 174 529 536 8769610 10.1093/infdis/174.3.529 1:STN:280:DyaK28zmsFCgsQ%3D%3D (Pubitemid 26299686)
26. PL Ho WM Chan KW Tsang SS Wong K Young 2002 Bacteremia caused by Escherichia coli producing extended-spectrum β-lactamase: a case-control study of risk factors and outcomes Scand J Infect Dis 34 567 573 12238570 10.1080/00365540210147516 (Pubitemid 35012337)
27. YK Kim H Pai HJ Lee, et al. 2002 Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome Antimicrob Agents Chemother 46 1481 1491 11959586 10.1128/AAC.46.5.1481-1491.2002 1:CAS:528:DC%2BD38XjtFKkt7g%3D (Pubitemid 34415332)